Joi vs Alloy for Women's Weight Loss & Hormones

Compare Joi vs Alloy for women's health. Detailed analysis of pricing, medications, doctor quality, and patient experience. Find the right platform for...

By Dr. James Walker, MD, MPH|Reviewed by Dr. David Kim, MD, FACE|Last reviewed April 1, 2026|Published January 9, 2026

Medically Reviewed

Written by Dr. James Walker, MD, MPH · Reviewed by Dr. David Kim, MD, FACE

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Choosing between Joi and Alloy for women's weight loss and hormone management requires understanding their distinct approaches to telehealth care. Both platforms target women seeking thorough health solutions, but they differ significantly in their medication offerings, pricing structures, and clinical oversight models.

Quick Verdict: Joi vs Alloy Comparison

Joi: What You Get

Joi positions itself as a weight loss telehealth platform specifically designed for women, focusing primarily on GLP-1 receptor agonist medications like semaglutide and tirzepatide. The platform launched in 2023 with the premise that women's weight loss needs differ from men's, requiring specialized approaches that account for hormonal fluctuations, metabolic differences, and lifestyle factors unique to women.

The consultation process begins with an online assessment covering medical history, current medications, weight loss goals, and lifestyle factors. Joi's medical team includes board-certified physicians and nurse practitioners who specialize in obesity medicine and women's health. After completing the initial assessment, patients typically receive a response within 24-48 hours regarding their eligibility for treatment.

FormBlends for women's weight loss

FormBlends prescribes compounded semaglutide and tirzepatide to patients who meet clinical criteria (BMI 27+ with comorbidity, or BMI 30+). The intake covers menstrual cycle, pregnancy plans, and thyroid history so the provider can screen for contraindications. Monthly cost starts at $199. Take the intake.

Joi Pricing Structure

Joi operates on a subscription model with three main tiers. The important plan starts at $149 per month and includes compounded semaglutide, monthly physician consultations, and basic nutritional guidance. The Premium plan costs $297 monthly and adds access to tirzepatide, enhanced coaching support, and priority customer service. The thorough plan reaches $399 per month, incorporating additional medications like metformin, detailed lab work analysis, and personalized meal planning.

All plans include the medication cost, shipping, and ongoing medical supervision. But patients must pay separately for required lab work, which typically costs $150-$300 depending on the panel ordered. Joi doesn't accept insurance for any of their services, positioning themselves as a cash-pay concierge model.

Available Medications Through Joi

Joi's medication offerings center around proven weight loss compounds. Their primary options include compounded semaglutide (starting at 0.25mg weekly, titrating up to 2.4mg), compounded tirzepatide (beginning at 2.5mg weekly, potentially reaching 15mg), and metformin for patients with insulin resistance concerns. The platform sources medications from FDA-registered 503B compounding pharmacies, ensuring quality standards while offering more affordable alternatives to brand-name options.

The clinical team emphasizes gradual dose escalation to minimize side effects, with most patients spending 4-6 weeks at each dose level before advancing. Joi provides detailed injection training through video tutorials and offers ongoing support for managing potential side effects like nausea, constipation, or fatigue.

Joi Pros and Cons

Pros:

• Lower starting price point compared to many competitors
• Access to both semaglutide and tirzepatide
• Women-focused approach with specialized protocols
• Fast shipping and responsive customer service
• thorough injection training and support materials

Cons:

• No hormone replacement therapy options
• Limited to weight loss medications only
• No insurance acceptance
• Additional costs for required lab work
• Relatively new platform with limited long-term data

Alloy: What You Get

Alloy takes a fundamentally different approach, positioning itself as a thorough women's health platform specializing in menopause and perimenopause management. Founded in 2021, Alloy recognizes that hormonal changes during midlife significantly impact weight, mood, energy, and overall quality of life. Their platform addresses these interconnected issues through hormone replacement therapy, lifestyle coaching, and targeted supplementation.

The Alloy experience begins with an extensive health assessment covering menstrual history, symptom tracking, family medical history, and current concerns. Their medical team consists of board-certified gynecologists, endocrinologists, and menopause specialists who understand the complex interaction between hormones and metabolic health. The initial consultation typically occurs within 48-72 hours of completing the assessment.

Alloy Pricing and Plans

Alloy structures their pricing around thorough care packages rather than individual medications. The Foundation plan starts at $199 monthly and includes hormone level testing, basic hormone replacement therapy, and access to their educational resources. The Complete plan costs $279 per month, adding advanced hormone improvement, nutritional counseling, and priority scheduling with specialists.

Their Premium plan reaches $349 monthly, incorporating advanced treatments like bioidentical hormone pellets, advanced metabolic testing, and personalized supplement protocols. Unlike many telehealth platforms, Alloy includes the cost of basic laboratory testing in their monthly fees, though more thorough panels may incur additional charges ranging from $100-$400.

Alloy's Hormone and Wellness Offerings

Alloy's strength lies in their thorough hormone replacement therapy options. They offer bioidentical estradiol in multiple formulations including patches, gels, and oral tablets. Progesterone options include both oral micronized progesterone and vaginal suppositories. For women experiencing low libido or energy, they provide testosterone therapy through creams or pellets.

Beyond hormones, Alloy addresses weight management through metabolic improvement rather than direct weight loss medications. Their approach includes thyroid hormone improvement, insulin sensitivity improvement through lifestyle modifications, and targeted supplementation with compounds like berberine, chromium, and omega-3 fatty acids.

The platform also provides extensive educational resources covering nutrition during menopause, exercise protocols for hormonal health, and stress management techniques. Their coaching team includes registered dietitians, certified personal trainers, and mental health counselors who understand the unique challenges of midlife transitions.

Alloy Pros and Cons

Pros:

• thorough hormone replacement therapy options
• Specialized focus on menopause and perimenopause
• Includes basic lab testing in monthly fees
• Access to multiple specialist types
• Extensive educational resources and community support
• Addresses root causes of midlife weight gain

Cons:

• Higher starting price point
• Limited direct weight loss medication options
• Primarily serves perimenopausal/menopausal women
• Longer shipping times for medications
• Complex treatment protocols may overwhelm some patients

Price Comparison: Joi vs Alloy

The pricing structures of Joi and Alloy reflect their different therapeutic focuses, making direct comparison challenging but important for informed decision-making. Joi's entry-level pricing at $149 monthly appears more accessible initially, but patients must factor in additional costs for laboratory monitoring, which Joi requires every 3-6 months depending on the medication protocol.

Alloy's starting price of $199 monthly includes basic hormone testing, which typically costs $200-$300 when ordered independently. This inclusion makes Alloy's effective first-year cost more competitive than initial pricing suggests. But both platforms require ongoing monthly commitments with most patients seeing meaningful results after 3-6 months of consistent treatment.

For patients requiring both weight loss support and hormone improvement, neither platform offers a complete solution. Joi excels in weight management but lacks hormone therapy, while Alloy addresses hormonal health thoroughly but provides limited direct weight loss interventions. Some women find themselves needing services from both platforms or seeking alternatives like FormBlends, which offers physician-supervised access to both GLP-1 medications and hormone improvement in a single integrated approach.

Insurance considerations add another layer of complexity. Neither platform accepts insurance, requiring patients to budget for out-of-pocket expenses. But some patients successfully use Health Savings Accounts or Flexible Spending Accounts to offset costs, particularly for medically necessary treatments like hormone replacement therapy.

Medication Options: Joi vs Alloy

The medication portfolios of these platforms reveal their core philosophical differences. Joi focuses exclusively on evidence-based weight loss compounds, primarily GLP-1 receptor agonists that have demonstrated significant efficacy in clinical trials. Semaglutide, their primary offering, showed average weight loss of 12-15% in the STEP clinical trial program, while tirzepatide demonstrated even greater efficacy with 15-22% weight reduction in the SURMOUNT studies.

Joi's approach emphasizes rapid, measurable weight loss through appetite suppression and delayed gastric emptying. Their protocols typically produce noticeable results within 4-8 weeks, with peak effects occurring around 16-20 weeks of treatment. The platform provides detailed guidance on managing side effects, which affect approximately 60-80% of patients initially but typically resolve within 2-4 weeks.

Alloy's medication strategy targets the underlying hormonal imbalances that contribute to midlife weight gain, mood changes, and energy decline. Their hormone replacement protocols aim to restore optimal estradiol levels (typically 100-200 pg/mL), adequate progesterone for cycle regulation and sleep quality, and sufficient testosterone for libido and muscle maintenance.

Research supports Alloy's approach for their target demographic. The Women's Health Initiative follow-up studies and more recent data from the KEEPS trial demonstrate that properly managed hormone replacement therapy can improve body composition, reduce visceral fat accumulation, and enhance metabolic function in perimenopausal and postmenopausal women.

The timeline for hormonal improvement differs significantly from direct weight loss medications. Patients typically notice initial improvements in sleep quality and hot flashes within 2-4 weeks, mood and energy changes around 6-8 weeks, and body composition improvements over 3-6 months. This longer timeline requires patience but often produces more sustainable long-term results.

Doctor Quality and Oversight

Both platforms emphasize physician oversight, but their approaches reflect their different therapeutic focuses. Joi's medical team consists primarily of obesity medicine specialists, family practitioners with additional training in weight management, and nurse practitioners experienced in GLP-1 therapies. Their physicians typically complete board certification in obesity medicine or hold additional credentials from organizations like the American Board of Obesity Medicine.

Joi's consultation model involves initial assessment, monthly check-ins during dose titration phases, and quarterly reviews once patients reach maintenance dosing. The platform uses standardized protocols for dose escalation and side effect management, ensuring consistent care quality across their provider network. But some patients report feeling rushed during consultations, with appointments typically lasting 10-15 minutes.

Alloy's physician network includes board-certified gynecologists, reproductive endocrinologists, and menopause specialists certified by the North American Menopause Society. Their doctors typically have 10+ years of experience in women's health and undergo additional training in bioidentical hormone therapy protocols.

Alloy's consultation model provides more thorough initial assessments, often lasting 30-45 minutes, with detailed discussion of symptoms, treatment goals, and potential risks. Follow-up appointments occur every 6-8 weeks initially, then quarterly once hormone levels stabilize. Patients consistently report feeling heard and understood by Alloy's providers, though scheduling can be challenging due to high demand.

Both platforms maintain appropriate medical oversight for their respective treatment areas. Joi excels in weight loss medication management with proper monitoring for contraindications and side effects. Alloy provides thorough hormone therapy oversight with appropriate screening for cardiovascular and cancer risks.

Patient Experience and Reviews

Patient satisfaction data reveals interesting patterns between these platforms. Joi users frequently praise the platform's straightforward approach, user-friendly app interface, and rapid results. Online reviews consistently mention significant weight loss within the first 2-3 months, with many patients losing 15-30 pounds during their initial treatment period.

But Joi patients also report challenges with side effect management, particularly during the initial weeks of treatment. Nausea, fatigue, and gastrointestinal issues affect the majority of users, though most find these symptoms manageable with proper support. Some patients express frustration with the limited scope of care, wishing for more thorough health improvement beyond weight loss.

Alloy patients typically report higher overall satisfaction with their care experience, particularly appreciating the thorough approach to midlife health concerns. Reviews frequently mention improvements in sleep quality, mood stability, energy levels, and overall quality of life beyond just physical symptoms.

The Alloy patient community appears more engaged, with active online forums and regular educational webinars. Patients appreciate feeling part of a supportive community addressing similar life stage challenges. But some users express frustration with the complexity of treatment protocols and the longer timeline for seeing results.

Both platforms maintain strong safety records with appropriate adverse event reporting and management protocols. Neither has faced significant regulatory scrutiny, and both demonstrate commitment to evidence-based practice within their respective specialties.

Which Is Right for You?

Choosing between Joi and Alloy depends primarily on your current life stage, primary health concerns, and treatment goals. Joi serves women of various ages seeking effective weight loss solutions, particularly those who have struggled with traditional diet and exercise approaches. The platform works best for patients comfortable with injection-based medications and seeking rapid, measurable results.

Ideal Joi candidates include women with BMI over 27 who have weight-related health concerns, those who have tried multiple weight loss approaches without success, and patients seeking a straightforward, medication-focused approach. Joi also suits women who prefer lower initial costs and don't require hormone therapy.

Alloy better serves women experiencing perimenopause or menopause symptoms, typically those aged 40-60 dealing with hormonal changes affecting their weight, mood, energy, and overall well-being. The platform excels for patients seeking thorough midlife health improvement rather than just weight loss.

Perfect Alloy candidates include women experiencing irregular periods, hot flashes, mood changes, decreased libido, or unexplained weight gain during their 40s and 50s. The platform also suits patients willing to invest in thorough care and comfortable with longer treatment timelines for sustainable results.

For women needing both significant weight loss support and hormone improvement, neither platform provides a complete solution. In these cases, exploring integrated platforms that offer both services may provide more thorough care. Some patients successfully combine services from multiple providers, though this approach increases complexity and cost.

Consider your insurance situation, budget constraints, and preferred communication style when making this decision. Both platforms require significant financial commitment, and success depends on consistent engagement with their protocols and recommendations.

Frequently Asked Questions

Can I use both Joi and Alloy simultaneously?

While not prohibited, using both platforms simultaneously requires careful coordination between providers to avoid medication interactions and ensure appropriate monitoring. Most patients find it more effective and cost-efficient to choose one platform or seek an integrated provider offering both services.

Do either Joi or Alloy accept insurance?

Neither platform accepts insurance directly. But some patients successfully use Health Savings Accounts or Flexible Spending Accounts for qualified medical expenses. some insurance plans may reimburse for telehealth consultations or laboratory testing when submitted with proper documentation.

How long do I need to stay on treatment with either platform?

Treatment duration varies significantly based on individual goals and response. Joi patients typically see optimal results after 6-12 months, with many choosing to continue long-term for weight maintenance. Alloy patients often require ongoing hormone therapy, particularly post-menopause, though dosing may be adjusted over time.

What happens if I experience side effects?

Both platforms provide 24/7 support for managing side effects. Joi offers detailed protocols for GLP-1 side effects like nausea and fatigue, while Alloy provides guidance for hormone therapy adjustments. Severe side effects warrant immediate consultation, and both platforms maintain protocols for urgent medical concerns.

Can I switch between platforms if my needs change?

Yes, patients can transition between platforms, though this requires coordination between medical teams and potential washout periods for certain medications. Both platforms provide medical records and treatment summaries to help with transitions when medically appropriate.

Ready to Start Your Weight Loss Goals?

Choosing the right telehealth platform for your weight loss and hormone health goals requires careful consideration of your individual needs, budget, and treatment preferences. While both Joi and Alloy offer valuable services within their specialties, some women benefit from platforms offering integrated approaches to weight management and hormonal health.

FormBlends provides physician-supervised access to both GLP-1 medications and hormone improvement therapies, potentially offering the thorough care that bridges the gap between these specialized platforms. Our medical team understands the complex relationship between hormones and weight management, providing personalized treatment plans that address both concerns simultaneously.

Whether you choose Joi, Alloy, or explore integrated alternatives, the most important step is beginning your progress toward better health. Read patient reviews and success stories to understand how different approaches might work for your unique situation, and remember that sustainable results require commitment, patience, and ongoing medical supervision regardless of the platform you choose.

Sources

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
3. Manson JE, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353-68.
4. Joi Health Official Website. Pricing and Services. Accessed March 2026.
5. Alloy Women's Health Official Website. Treatment Options and Costs. Accessed March 2026.
6. North American Menopause Society. The 2022 hormone therapy position statement. Menopause. 2022;29(7):767-794.
7. Kushner RF, et al. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity. 2020;28(6):1050-1061.

Editorial refresh

Practical 2026 note for Joi vs Alloy for Women's Weight Loss & Hormones

Joi vs Alloy for Women's Weight Loss & Hormones now carries extra 2026 context around semaglutide, tirzepatide, testosterone, hormone therapy, cash-pay pricing, safety signals, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.

Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to joi vs alloy womens.

Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.

Custom 2026 image for Joi vs Alloy for Women's Weight Loss & Hormones, provider comparisons, and better treatment decision-making.